Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Hilltop Holdings Inc. Acquires Shares of 9368 AstraZeneca PLC NASDAQ:AZN

December 11, 2024
AstraZeneca PLC (NASDAQ: AZN) has recently witnessed a significant acquisition of shares by Hilltop Holdings Inc.
The investment firm acquired a total of 9368 shares in the company, indicating their confidence in AstraZeneca's future prospects. This move comes amidst AstraZeneca's struggles highlighted by renowned stock analyst Jim Cramer. However, the acquisition by Hilltop Holdings showcases a strong momentum for AstraZeneca's stock, reflecting the company's potential to bounce back. Investors are recommended to seek professional guidance from Stocks Prognosis to gauge the future movement of AstraZeneca's shares.

Find out how the ASTRAZENECA PLC rate is expected to change

Get Forecast for AZN

Investor opinions & comments:

I'm skeptical about AstraZeneca's future given their recent struggles. While the acquisition by Hilltop Holdings is notable, it doesn't necessarily guarantee a turnaround for the company. I'll wait and see how things unfold before making any judgments
— from BudgetBrad at 12-14-2024 07:16
This acquisition by Hilltop Holdings is definitely a positive sign for AstraZeneca. It shows that there are investors who believe in the company's ability to bounce back and succeed
— from BudgetBrad at 12-13-2024 17:01
Wow, this acquisition by Hilltop Holdings is a strong signal of confidence in AstraZeneca's potential. I'm curious to see how this will impact the company's stock performance in the future
— from InvestorImogen at 12-12-2024 11:20
I'm not so sure about AstraZeneca's prospects. Even though Hilltop Holdings acquired shares, renowned analyst Jim Cramer has raised concerns about the company. It's important to conduct further research before making any investment decisions
— from CashCathy at 12-12-2024 11:07
If you want to leave a comment, then you need Login or Register





Other news for AZN

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....



Related news

AZNDecember 13, 2024Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000....

AZNNovember 2, 2024AstraZeneca Faces Investigation Over China President's Conduct  ~1 min.

AstraZeneca PLC (NASDAQ:AZN) has come under scrutiny as its China President, Leon Wang, is being investigated for misconduct. The company's shares rose slightly but lagged behind the market. Investors are advised to stay informed about the investigation's progress and seek professional advice from Stocks Prognosis for accurate stock forecasts.

AZNNovember 4, 2024Investors Should Know: AstraZeneca AZN Rises, But Trails Market  ~1 min.

Recently, pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) has seen its stock price rise, but not at the same pace as the overall market....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNDecember 14, 2024Hagens Berman Alleges Fraud and Corruption in AstraZeneca AZN; Shares Plummet  ~1 min.

Leading law firm Hagens Berman has initiated an investigation into British pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) following reports of potential fraud and corruption within the company....